ask="3.77"
ask_size="500"
average_daily_volume="43692"
bid="1.00"
bid_size="200"
book_value="-0.93"
change="+0.07"
change_from_200_day_moving_average="-0.88"
change_from_50_day_moving_average="-0.49"
change_from_52_week_high="-2.76"
change_From_52_week_low="0.93"
change_in_percent="+2.63%"
close="2.73"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.26"
ebitda="-50.77M"
eps_estimate_current_year="-1.26"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.81"
ex_dividend_date="N/A"
float_shares="10398000"
high="2.81"
high_52_weeks="5.49"
last_trade_date="3/8/2017"
last_trade_price="2.73"
last_trade_size="129"
last_trade_time="4:00pm"
low="2.61"
low_52_weeks="1.80"
market_capitalization="64.51M"
moving_average_200_day="3.61"
moving_average_50_day="3.22"
name="Oncobiologics
Inc."
notes="N/A"
one_year_target_price="11.00"
open="2.68"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-24.35%"
percent_change_from_50_day_moving_average="-15.24%"
percent_change_from_52_week_high="-50.27%"
percent_change_from_52_week_low="+51.34%"
previous_close="2.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="27.48"
revenue="2.29M"
shares_outstanding="23631000"
short_ratio="0.89"
stock_exchange="NGM"
symbol="ONS"
volume="18350"
weeks_range_52="1.80 - 5.49"
